Dosage Appropriacy Evaluation of Oral Venlafaxine Related to CYP2D6 Genotype Using Physiologically Based Pharmacokinetic (PBPK) Model

被引：0
|
作者：
Cho, Changkeun [1 ]
机构：
[1] Sungkyunkwan Univ, Seoul, South Korea
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.03769
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype
    Mannheimer, Buster
    Haslemo, Tore
    Lindh, Jonatan D.
    Eliasson, Erik
    Molden, Espen
    THERAPEUTIC DRUG MONITORING, 2016, 38 (01) : 127 - 134
  • [42] CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis
    Doki, Kosuke
    Homma, Masato
    Kuga, Keisuke
    Aonuma, Kazutaka
    Kohda, Yukinao
    PHARMACOGENETICS AND GENOMICS, 2012, 22 (11): : 777 - 783
  • [43] DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR VENLAFAXINE AND O-DESME THY LVENLA FAXINE: ASSESSING THE IMPACT OF CYP2D6, CYP2C9 AND CYP2C19 GENETIC POLYMORPHISMS
    Pan, X.
    Rowland-Yeo, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S103 - S104
  • [44] Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping
    Frank, D.
    Jaehde, U.
    Fuhr, U.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (04) : 321 - 333
  • [45] Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping
    D. Frank
    U. Jaehde
    U. Fuhr
    European Journal of Clinical Pharmacology, 2007, 63 : 321 - 333
  • [46] Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
    Lisa Alina Kneller
    Georg Hempel
    Pharmaceutical Research, 2020, 37
  • [47] A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia
    Locatelli, Igor
    Kastelic, Matej
    Koprivsek, Jure
    Kores-Plesnicar, Blanka
    Mrhar, Ales
    Dolzan, Vita
    Grabnar, Iztok
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 41 (02) : 289 - 298
  • [48] Modelling Age-Related Changes in the Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Different CYP2D6 Phenotypes Using a Physiologically Based Pharmacokinetic Approach
    Kneller, Lisa Alina
    Hempel, Georg
    PHARMACEUTICAL RESEARCH, 2020, 37 (06)
  • [49] The First Physiologically Based Pharmacokinetic (PBPK) Model for an Oral Vaccine Using Alpha-Tocopherol as an Adjuvant
    Saldanha, Leonor
    Vale, Nuno
    PHARMACEUTICS, 2023, 15 (09)
  • [50] CYP2D6 genotype related to tamoxifen efficacy: An analysis with exclusion of potential fake CYP2D6 genotype assignment caused by loss of hetcrozygosity in tumor tissue
    Dezentje, Vincent O.
    van Schalk, Ron H. N.
    Vietter-Bogaartz, Judith M.
    van der Straaten, Tahar
    Wessels, Judith A. M.
    Kranertharg, Elma Meershoek-Klein
    Berns, Els M. J. J.
    Seynaeve, Caroline
    Putter, Hein
    Van de Velde, Cornelis J. H.
    Nortier, J. W. R.
    Gelderblom, Hans
    Guchelaar, Henk-jan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345